Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees

Due to the rapid global spread of the Omicron (B.1.1.529) variant, efforts to scale up COVID-19 booster vaccination have been improved, especially in light of the increasing evidence of reduced neutralizing antibody (NT Ab) over time in vaccinated subjects. In this study, neutralizing antibody respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Anichini, Gabriele, Terrosi, Chiara, Gandolfo, Claudia, Gori Savellini, Gianni, Fabrizi, Simonetta, Miceli, Giovanni Battista, Franchi, Federico, Cusi, Maria Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144393/
https://www.ncbi.nlm.nih.gov/pubmed/35632563
http://dx.doi.org/10.3390/vaccines10050808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144393/
https://www.ncbi.nlm.nih.gov/pubmed/35632563
http://dx.doi.org/10.3390/vaccines10050808

Ejemplares similares